KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Intangibles (2016 - 2025)

Gsk (GSK) has 5 years of Intangibles data on record, last reported at $19.9 billion in Q4 2024.

  • For Q4 2024, Intangibles changed N/A year-over-year to $19.9 billion; the TTM value through Dec 2024 reached $19.9 billion, changed N/A, while the annual FY2024 figure was $19.8 billion, N/A changed from the prior year.
  • Intangibles reached $19.9 billion in Q4 2024 per GSK's latest filing, up from $16.8 billion in the prior quarter.
  • Across five years, Intangibles topped out at $19.9 billion in Q4 2024 and bottomed at $16.8 billion in Q4 2022.